ESMO guidelines

This page is a gathering place for the European Society of Medical Oncology (ESMO) guidelines that do not clearly fit under a disease-specific page. For more general guidelines, please visit this page.
Given the rapid change in evidence in many areas of hematology/oncology, readers are encouraged to consider any guideline published 5+ years ago to be for historical purposes, only.
=Guidelines=
==Anxiety and Depression==
*2023: Grassi et al. Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline EuroPMC
==Cancer cachexia==
*2021: Arends et al. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines EuroPMC
==Cancer pain==
*2009: Jost & Roila. Management of cancer pain: ESMO clinical recommendations EuroPMC
==Caregiver Communication and Support==
*2024: Stiefel et al. Communication and support of patients and caregivers in chronic cancer care: ESMO Clinical Practice Guideline EuroPMC
==Dyspnea==
*2020: Hui et al. Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines EuroPMC
==End of life==
*2023: Stone et al. Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline EuroPMC
*2021: Crawford et al. Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines EuroPMC
==Febrile neutropenia==
*2009: Marti et al. Management of febrile neutropenia: ESMO clinical recommendations EuroPMC
==Fertility & Pregnancy==
*2013: Peccatori et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up EuroPMC
**2010: Pentheroudakis et al. Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up EuroPMC
**2009: Pentheroudakis et al. Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up EuroPMC
**2008: Pentheroudakis et al. Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up EuroPMC
==Growth factors==
*2010: Crawford et al. Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applications EuroPMC
**2009: Crawford et al. Hematopoietic growth factors: ESMO recommendations for the applications EuroPMC
**2008: Greil et al. Hematopoietic growth factors: ESMO recommendations for the applications EuroPMC
**2007: Greil & Psenak. Hematopoietic growth factors: ESMO recommendations for the application EuroPMC
**2005: Greil & Jost. ESMO recommendations for the application of hematopoietic growth factors EuroPMC
*2009: Scrijvers & Roila. Erythropoiesis-stimulating agents in cancer patients: ESMO recommendations for use EuroPMC
==Insomnia==
*2023: Grassi et al. Insomnia in adult patients with cancer: ESMO Clinical Practice Guideline EuroPMC
==Mucositis==
*2011: Peterson et al. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines EuroPMC
**2009: Peterson et al. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations EuroPMC
**2008: Peterson et al. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations EuroPMC
==Precision oncology==
*2024: Mosele et al. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group EuroPMC
**2020: Mosele et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group EuroPMC
==Symptoms==
*2020: Santini et al. Management of orphan symptoms: ESMO Clinical Practice Guidelines for diagnosis and treatment EuroPMC
Category:Guideline pages